VR Logo

NeuroMetrix Inc. (NURO) download report


Healthcare | Medical Devices & Equipment

NeuroMetrix Inc. (NURO) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico.

IPO Date: 02-Jan-2001

Founder, Chairman, CEO, Pres & Sec.: Dr. Shai N. Gozani M.D., Ph.D.

Sr. VP, CFO & Treasurer: Mr. Thomas T. Higgins

Listing: NASDAQ: NURO

Country: United States

Headquarters: Woburn, MA

Website: https://www.neurometrix.com

Key Facts

Market cap: $25.95 Mln

Revenue (TTM): $8.40 Mln

Earnings (TTM): $-3.18 Mln

Cash: $23.77 Mln

Total Debt: $0.43 Mln

Insider's Holding: 1.03%

Liquidity: Low

52 Week range: $2.70 - 38.75

Shares outstanding: 7,130,090

10 Years Aggregate:

  • CFO: $-69.14 Mln
  • EBITDA: $-73.83 Mln
  • Net Profit: $-70.88 Mln

Stock Performance

Time Period NeuroMetrix (NURO) S&P BSE Sensex S&P Small-Cap 600
YTD-26.29-9.49-17.79
1 month-17.41-2.87-2.72
3 months-11.27-8.59-12.17
1 Year2.780.81-15.82
3 Years-10.8710.397.14
5 Years-33.9811.116.20
10 Years-43.8612.0010.33
As on 24-Jun-2022
Year NeuroMetrix (NURO) S&P Small-Cap 600 S&P BSE Sensex
202158.8625.2721.99
2020-26.519.5715.75
2019-43.4220.8614.38
2018-55.85-9.705.87
2017-70.7411.7327.91
2016-62.7024.741.95
2015-74.62-3.36-5.03